Review articleDevelopment of combretastatins as potent tubulin polymerization inhibitors

Add time:08/31/2019    Source:sciencedirect.com

The combretastatins are isolated from South African tree combretum caffrum kuntze. The lead compound combretastatin A-4 has displayed remarkable cytotoxic effect in a wide variety of preclinical tumor models and inhibits tubulin polymerization by interacting at colchicine binding site of microtubule. However, the structural simplicity of C A-4 is favorable for synthesis of various derivatives projected to induce rapid and selective vascular shutdown in tumors. Majority of the molecules have shown excellent antiproliferative activity and are able to inhibit tubulin polymerization as well as possible mechanisms of action have been investigated. In this review article, the synthesis and structure-activity relationships of C A-4 and immense number of its synthetic derivatives with various modifications on the A, B-rings, bridge carbons and their anti mitotic activities are discussed.

We also recommend Trading Suppliers and Manufacturers of Combretastatin A-3 (cas 111394-45-7). Pls Click Website Link as below: cas 111394-45-7 suppliers

Prev:Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug
Next:Full length articleCo-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma)